VIYASH: Audited FY26 Results Approved, ESOP 2026 Granted, AOA Adopted
Viyash Scientific Limited's Board approved audited standalone and consolidated financial results for the year ended March 31, 2026. They adopted a new AOA, pending shareholder approval, and granted 1,30,98,000 stock options under the 'Viyash Scientific Limited Employee Stock Option Scheme 2026'. No dividend was recommended for FY 2025-26.
The approval of financial results and ESOP grant are standard corporate actions. Adoption of new AOA and not declaring dividend may have moderate impact.
The announcement covers routine business operations such as financial results approval, adoption of new articles, and granting of stock options. There is no indication of a positive or negative outlook.
Viyash Scientific Limited (formerly Sequent Scientific Limited) announced the outcomes of its Board Meeting held on May 19, 2026. The Board approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. Additionally, the Board adopted a new set of Articles of Association (AOA) subject to shareholder approval.
Furthermore, the Board, based on the recommendation of the Nomination and Remuneration Committee, approved the grant of 1,30,98,000 (One Crore Thirty Lakh Ninety-Eight Thousand) stock options to eligible employees under the “Viyash Scientific Limited Employee Stock Option Scheme 2026”. The company is not a Large Corporate for FY 2025-26.
The Board meeting commenced at 3:00 p.m. and concluded at 4:56 p.m. The Board has not recommended any dividend for FY 2025-26 to conserve resources.
What to do with a filing like this
Viyash Scientific Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Viyash Scientific Limited. Read the original for the full detail.